<div class="at-above-post addthis tool" data-url="https://www.metro.us/covid-vaccine-reducing-risk/"></div>LONDON (Reuters) – Scotland’s vaccination drive appears to be markedly reducing the risk of hospitalisation for COVID-19, suggesting that both the Pfizer-BioNtech and Oxford-AstraZeneca shots are highly effective in preventing severe infections, preliminary study findings showed on Monday. Results of the study, which covered the entire Scottish population of 5.4 million people, showed that by […]<! AddThis Advanced Settings above via filter on get the excerpt ><! AddThis Advanced Settings below via filter on get the excerpt ><! AddThis Advanced Settings generic via filter on get the excerpt ><! AddThis Share Buttons above via filter on get the excerpt ><! AddThis Share Buttons below via filter on get the excerpt ><div class="at-below-post addthis tool" data-url="https://www
Vaccines substantially reduce COVID-19 hospitalisations: Scotland study
About 650,000 people in Scotland received the Pfizer vaccine during the study period and 490,000 had the AstraZeneca shot, according to the Usher Institute.
Share Via Email
| A+A A- By PTI
LONDON: Hospitalisations with COVID-19 were substantially reduced after the first dose of the two-dose Pfizer/BioNtech and Oxford/AstraZeneca vaccines by 85 per cent and 94 per cent respectively, a first-of-its-kind assessment of the UK s vaccine rollout programme revealed on Monday.
A research led by the Public Health Scotland (PHS) found at four weeks after the first dose, hospital admissions were reduced by 85 per cent for the Pfizer/BioNtech and 94 per cent Oxford/AstraZeneca jabs the two vaccines currently being administered UK-wide by the National Health Service (NHS).